Skip to main content
SpringerLink
Log in

Falsified data gets India's largest generic drug-maker into trouble

  • News
  • Published:

From Nature

View current issue Submit your manuscript

US Federal Drug Administration withdraws approval for a score of drugs from Ranbaxy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

Ranbaxy

Food and Drug Administration

Generic Pharmaceutical Association

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Falsified data gets India's largest generic drug-maker into trouble. Nature (2009). https://doi.org/10.1038/news.2009.130

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2009.130

  • Springer Nature Limited

Search

Navigation